1. Home
  2. PCRX vs HLIT Comparison

PCRX vs HLIT Comparison

Compare PCRX & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • HLIT
  • Stock Information
  • Founded
  • PCRX 2006
  • HLIT 1988
  • Country
  • PCRX United States
  • HLIT United States
  • Employees
  • PCRX N/A
  • HLIT N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • PCRX Health Care
  • HLIT Technology
  • Exchange
  • PCRX Nasdaq
  • HLIT Nasdaq
  • Market Cap
  • PCRX 1.2B
  • HLIT 1.0B
  • IPO Year
  • PCRX 2011
  • HLIT 1995
  • Fundamental
  • Price
  • PCRX $26.67
  • HLIT $9.62
  • Analyst Decision
  • PCRX Buy
  • HLIT Buy
  • Analyst Count
  • PCRX 6
  • HLIT 6
  • Target Price
  • PCRX $30.00
  • HLIT $11.50
  • AVG Volume (30 Days)
  • PCRX 766.6K
  • HLIT 1.1M
  • Earning Date
  • PCRX 08-05-2025
  • HLIT 10-27-2025
  • Dividend Yield
  • PCRX N/A
  • HLIT N/A
  • EPS Growth
  • PCRX N/A
  • HLIT 16.91
  • EPS
  • PCRX N/A
  • HLIT 0.58
  • Revenue
  • PCRX $705,848,000.00
  • HLIT $689,084,000.00
  • Revenue This Year
  • PCRX $7.36
  • HLIT N/A
  • Revenue Next Year
  • PCRX $10.07
  • HLIT $25.21
  • P/E Ratio
  • PCRX N/A
  • HLIT $16.62
  • Revenue Growth
  • PCRX 2.25
  • HLIT 24.14
  • 52 Week Low
  • PCRX $12.61
  • HLIT $7.80
  • 52 Week High
  • PCRX $27.64
  • HLIT $15.46
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 67.86
  • HLIT 61.09
  • Support Level
  • PCRX $25.14
  • HLIT $8.67
  • Resistance Level
  • PCRX $27.04
  • HLIT $9.16
  • Average True Range (ATR)
  • PCRX 0.78
  • HLIT 0.27
  • MACD
  • PCRX 0.18
  • HLIT 0.10
  • Stochastic Oscillator
  • PCRX 88.79
  • HLIT 83.34

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: